FR2502951B1 - Compositions pharmaceutiques topiques sous forme d'une micro-emulsion - Google Patents

Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Info

Publication number
FR2502951B1
FR2502951B1 FR8205611A FR8205611A FR2502951B1 FR 2502951 B1 FR2502951 B1 FR 2502951B1 FR 8205611 A FR8205611 A FR 8205611A FR 8205611 A FR8205611 A FR 8205611A FR 2502951 B1 FR2502951 B1 FR 2502951B1
Authority
FR
France
Prior art keywords
emulsion
micro
pharmaceutical compositions
topical pharmaceutical
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8205611A
Other languages
English (en)
French (fr)
Other versions
FR2502951A1 (fr
Inventor
Joachim Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2502951A1 publication Critical patent/FR2502951A1/fr
Application granted granted Critical
Publication of FR2502951B1 publication Critical patent/FR2502951B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8205611A 1981-04-06 1982-03-30 Compositions pharmaceutiques topiques sous forme d'une micro-emulsion Expired FR2502951B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (2)

Publication Number Publication Date
FR2502951A1 FR2502951A1 (fr) 1982-10-08
FR2502951B1 true FR2502951B1 (fr) 1985-12-06

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8205611A Expired FR2502951B1 (fr) 1981-04-06 1982-03-30 Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Country Status (16)

Country Link
AU (1) AU564570B2 (enrdf_load_stackoverflow)
CA (1) CA1192496A (enrdf_load_stackoverflow)
DE (1) DE3212053A1 (enrdf_load_stackoverflow)
DK (1) DK155882A (enrdf_load_stackoverflow)
ES (1) ES8308698A1 (enrdf_load_stackoverflow)
FI (1) FI821123L (enrdf_load_stackoverflow)
FR (1) FR2502951B1 (enrdf_load_stackoverflow)
GB (2) GB2098865B (enrdf_load_stackoverflow)
GR (1) GR75462B (enrdf_load_stackoverflow)
IL (1) IL65424A0 (enrdf_load_stackoverflow)
IT (1) IT8220611A0 (enrdf_load_stackoverflow)
MY (1) MY8600571A (enrdf_load_stackoverflow)
NL (1) NL8201413A (enrdf_load_stackoverflow)
NZ (1) NZ200232A (enrdf_load_stackoverflow)
PT (1) PT74703B (enrdf_load_stackoverflow)
SE (1) SE8202172L (enrdf_load_stackoverflow)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (enrdf_load_stackoverflow) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
KR920010392B1 (ko) * 1984-03-01 1992-11-27 산도즈 아크리엔 게젤샤프트 경피투여용 약학 조성물의 제조방법
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
DK0580778T3 (da) * 1991-04-19 2000-01-31 Lds Technologies Inc Konvertible mikroemulsionsformuleringer
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp COMPOSITIONS FOR PHARMACEUTICAL EMULSIONS.
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
SG115386A1 (en) 1997-01-30 2005-10-28 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (enrdf_load_stackoverflow) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
AU775523B2 (en) * 1998-12-11 2004-08-05 Pharmasolutions, Inc. Self-emulsifying compositions for drugs poorly soluble in water
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
DE602004028284D1 (de) 2003-12-08 2010-09-02 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (enrdf_load_stackoverflow) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
AU8233482A (en) 1982-10-14
GB2148711B (en) 1985-12-18
FI821123A0 (fi) 1982-03-31
NL8201413A (nl) 1982-11-01
IL65424A0 (en) 1982-07-30
DE3212053A1 (de) 1982-10-21
NZ200232A (en) 1985-08-16
FI821123A7 (fi) 1982-10-07
FR2502951A1 (fr) 1982-10-08
GB8408654D0 (en) 1984-05-16
GR75462B (enrdf_load_stackoverflow) 1984-07-20
AU564570B2 (en) 1987-08-20
FI821123L (fi) 1982-10-07
GB2148711A (en) 1985-06-05
ES511169A0 (es) 1983-10-01
PT74703B (en) 1984-05-30
SE8202172L (sv) 1982-10-07
DK155882A (da) 1982-12-10
ES8308698A1 (es) 1983-10-01
GB2098865B (en) 1985-12-18
PT74703A (en) 1982-05-01
GB2098865A (en) 1982-12-01
CA1192496A (en) 1985-08-27
IT8220611A0 (it) 1982-04-06
MY8600571A (en) 1986-12-31

Similar Documents

Publication Publication Date Title
FR2502951B1 (fr) Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2636532B1 (fr) Compositions pharmaceutiques
FR2547727B1 (fr) Compositions pharmaceutiques
FR2540726B1 (fr) Compositions pharmaceutiques anti-inflammatoires pour l'usage topique, leur preparation et leurs utilisations
NL192201B (nl) Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en prepa- raten die deze verbindingen bevatten.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2601588B1 (fr) Compositions pharmaceutiques a activite systemique pour l'application topique
BE888082A (fr) Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau
IT1146993B (it) Perfezionamento nelle spolette di prossimita'
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
IT7822019A0 (it) Composizione farmaceutica adattivita' antibroncospastica e antitosse.
FR2609391B1 (fr) Preparations pharmaceutiques sous forme de suppositoires bioadhesifs
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
IT1166667B (it) Meccanismo d'interbloccaggio di formulazione d'indirizzo
IT1161213B (it) Composizioni farmaceutiche ad attivita' antineoplastica
FR2505826B1 (fr) Derives d'isoprenylamine et compositions pharmaceutiques preparees avec ces derives
BE876767A (fr) Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs
DE3268487D1 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives, their preparation and pharmaceutical compositions
OA06373A (fr) Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.
FR2468162B1 (fr) Calculateur produisant une information sous la forme d'une voix synthetisee
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.

Legal Events

Date Code Title Description
ST Notification of lapse